Home » Topics » Disease categories and therapies » Immune

Immune
RSS

NIH offers malaria vaccine technology for licensing

April 3, 1998

Zenapax launched in Switzerland

March 17, 1998

Immunosuppressive analogues of a natural immunostimulant

March 16, 1998

New malaria vaccine described in patent literature

March 16, 1998

Novel immunomodulatory agents described by Takeda

March 12, 1998

Alliance formed for development of oral vaccines from plants

March 11, 1998

PGG-glucan displays potent protective effects in guinea pig model

March 10, 1998

PowderJect and Glaxo Wellcome enter DNA vaccine collaboration

March 10, 1998

Boston Life Sciences licenses BCLx-gamma gene from Harvard

March 10, 1998

Zenapax approved in Switzerland

March 5, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...